Literature DB >> 11857052

Description of three new polymorphisms in the intronic and 3'UTR regions of the human interferon gamma gene.

S Henri1, F Stefani, D Parzy, C Eboumbou, A Dessein, C Chevillard.   

Abstract

Interferon-gamma (IFN-gamma) is a key regulator of the development and functions of the immune system. In particular, this cytokine plays a major role in immune defense against infections by various human pathogens and polymorphisms in the IFN-gamma gene, including the transcription regulatory region, and might affect host resistance to infectious agents such as schistosomes. In this study on the genetics of human schistosomiasis we uncovered three new single nucleotide polymorphisms in the IFN-gamma genes. Two polymorphisms are located in the third intron and the third is in the 3'UTR region of this gene: an A to G transition at position +2109 from the transcription start and two G to A transitions at positions +3810 and +5134. In a SUDANESE population living in an endemic area of malaria and schistosomiasis, the allelic frequenciesare: 0.85 (+2109A), 0.15 (+2109G), 0.92 (+3810G), 0.08 (+3810A), (+5134G) and 0.04 (+5134A).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857052     DOI: 10.1038/sj.gene.6363809

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  9 in total

1.  The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.

Authors:  Jamal Sarvari; Afagh Moattari; Neda Pirbonyeh; Maryam Moini; Seyed Younes Hosseini
Journal:  J Clin Lab Anal       Date:  2015-05-20       Impact factor: 2.352

2.  Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection.

Authors:  Meiqiang Liu; Bangwei Cao; Hongkun Zhang; Yue Dai; Xiaolin Liu; Changqing Xu
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

3.  IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians.

Authors:  C C Cardoso; A C Pereira; V N Brito-de-Souza; I M Dias-Baptista; V C Maniero; J Venturini; F R Vilani-Moreno; F C de Souza; M Ribeiro-Alves; E N Sarno; A G Pacheco; M O Moraes
Journal:  Hum Genet       Date:  2010-08-17       Impact factor: 4.132

Review 4.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

5.  No association of IFNG+874T/A SNP and NOS2A-954G/C SNP variants with nitric oxide radical serum levels or susceptibility to tuberculosis in a Brazilian population subset.

Authors:  Ana Cristina C S Leandro; Márcia Andrade Rocha; Andreia Lamoglia-Souza; John L VandeBerg; Valeria Cavalcanti Rolla; Maria da Gloria Bonecini-Almeida
Journal:  Biomed Res Int       Date:  2013-08-18       Impact factor: 3.411

6.  Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population.

Authors:  Yu Yang; Xiangwei Li; Wei Cui; Ling Guan; Fei Shen; Jinsheng Xu; Feng Zhou; Mufei Li; Cong Gao; Qi Jin; Jianmin Liu; Lei Gao
Journal:  BMC Infect Dis       Date:  2013-10-31       Impact factor: 3.090

7.  Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.

Authors:  Hongguang Li; Fangfeng Liu; Huaqiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jinhua Hu
Journal:  Med Sci Monit       Date:  2016-02-19

8.  Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment.

Authors:  Eliana Peresi; Larissa Ragozo Cardoso Oliveira; Weber Laurentino da Silva; Erika Alessandra Pellison Nunes da Costa; João Pessoa Araujo; Jairo Aparecido Ayres; Maria Rita Parise Fortes; Edward A Graviss; Ana Carla Pereira; Sueli Aparecida Calvi
Journal:  Tuberc Res Treat       Date:  2013-03-27

9.  The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran.

Authors:  Jamal Sarvari; Hossin Norozian; Mohamad Reza Fattahi; Neda Pirbonyeh; Afagh Moattari
Journal:  Hepat Mon       Date:  2014-01-23       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.